drugset / Trial / NCT00348400

Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost

NCT00348400

Phase 4 Completed Innovative Medical
RandomizedParallel-groupSingle-blind

Summary

Evaluate the relative efficacy and tolerability of Alphagan P compared to Trusopt as adjunctive therapy

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Brimonidine Small molecule 0.15 %
Subject Dorzolamide Small molecule 2 %
Background Latanoprost Small molecule

Indications